glp-1 inflammatory bowel disease Role of glucagon-like peptides in diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology Pharmacological interventions for obesity in

How Do GLP-1 Drugs Cause Muscle Loss

Nutritional strategies for maintaining muscle mass and strength from middle age to later life: a narrative review

PMID 11479571

Study findings The present study results revealed a significant delay in alcohol's effects in cases compared to controls

These short-chain fatty acids serve as fuel for colonocytes and create an environment that favors the growth of beneficial bacteria, particularly Akkermansia muciniphila

This once-weekly injection was shown to lead to an average reduction of 20.9% in body weight during trials, making it an excellent option for those who need substantial weight loss or haven't succeeded with single-agonist treatments